tiprankstipranks
Trending News
More News >
Cellectis SA (CLLS)
NASDAQ:CLLS

Cellectis SA (CLLS) Similar Stocks

Compare
933 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Cellectis SA
$1.47
$108.78M
-49.31%
2 Buy
2 Hold
0 Sell
Moderate Buy
Editas Medicine
$1.55
$137.29M
-72.47%
5 Buy
6 Hold
1 Sell
Moderate Buy
Nkarta
$1.76
$125.24M
-73.24%
5 Buy
1 Hold
0 Sell
Strong Buy
4D Molecular Therapeutics
$3.60
$166.77M
-86.12%
6 Buy
0 Hold
1 Sell
Moderate Buy
Vor Biopharma
$0.19
$23.34M
-89.07%
1 Buy
6 Hold
0 Sell
Hold
Caribou Biosciences
$1.10
$102.31M
-66.11%
5 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CLLS
Cellectis SA
1.47
-1.35
-47.87%
EDIT
Editas Medicine
1.55
-4.08
-72.47%
NKTX
Nkarta
1.75
-4.69
-72.83%
FDMT
4D Molecular Therapeutics
3.49
-21.66
-86.12%
VOR
Vor Biopharma
0.18
-1.38
-88.46%
CRBU
Caribou Biosciences
1.02
-1.95
-65.66%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis